Interestingly, two recent immunohistochemical investigations have shown a correlation between COX-1 overexpression and poor prognosis in RCC [48], and the validity of the combined use of COX-1 and VEGF in RCC histopathologic prognosis [49]. This evidence concerns the gene PTGS1 and renal cell carcinoma.